BioCentury
DATA GRAPHICS | Finance

Data Bytes: led by ex-U.S. biopharmas, July follow-ons bring in $5.8B

August 5, 2020 1:18 AM UTC

July saw $5.8 billion in follow-on capital raised across 36 biopharma offerings, bringing the year’s total so far to $28 billion. Two of the month’s three largest follow-ons came from companies based in China.

Shanghai Junshi Biosciences Co. Ltd. (HKEX:1877; Shanghai:688180) had July’s largest raise, bringing in RMB4.8 billion ($683.2 million) from its debut on Shanghai’s STAR market. The biotech is collaborating with Eli Lilly and Co. (NYSE:LLY) to develop a mAb therapy for COVID-19...